Paper35342000
Drug resistant TB - latest developments in epidemiology, diagnostics and management.
Tiberi S and 7 others. Int J Infect Dis, 2022. Cited by 122 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Drug resistant TB - latest developments in epidemiology, diagnostics and management. Papers, record 35342000. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35342000
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Extensively Drug-Resistant Tuberculosis | Major topic |
| Tuberculosis, Multidrug-Resistant | Major topic |
| Mycobacterium tuberculosis | Major topic |
| Humans | |
| Antitubercular Agents | |
| Isoniazid | |
| Rifampin |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 001 | World Health Organization | International | PubMed |
Source PubMed
Cited by92
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 122 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,971,965 | Risk stratification for MDR/RR-TB: a comprehensive integrated patient-level analysis from TB programs and contemporary clinical trials. | Nat Commun | 2026 | https://conductscience.org/library/papers/42971965 | PubMed |
| 42,583,028 | Direct medical costs for drug-resistant tuberculosis inpatients at the national lung hospital, Vietnam: A one-year study. | J Public Health Res | 2026 | https://conductscience.org/library/papers/42583028 | PubMed |
| 42,565,573 | [Drug resistance characteristics of pulmonary tuberculosis and factors associated with rifampicin resistance in Changsha from 2018 to 2025]. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2026 | https://conductscience.org/library/papers/42565573 | PubMed |
| 42,430,436 | Machine learning-based analysis of drug resistance mutations in Mycobacterium tuberculosis. | PLoS One | 2026 | https://conductscience.org/library/papers/42430436 | PubMed |
| 42,391,193 | A high centrifugal force-enhanced Ziehl-Neelsen method for improved detection of Mycobacterium tuberculosis. | PLoS One | 2026 | https://conductscience.org/library/papers/42391193 | PubMed |
| 42,224,160 | Experiences and understanding of diagnosis and treatment among drug-resistant extrapulmonary tuberculosis patients: A qualitative study from Central India. | PLOS Glob Public Health | 2026 | https://conductscience.org/library/papers/42224160 | PubMed |
| 42,221,368 | Drug-Resistant Tuberculosis Outcomes in South Kivu Province, Democratic Republic of Congo, During a Humanitarian Crisis (2018-2024). | Open Forum Infect Dis | 2026 | https://conductscience.org/library/papers/42221368 | PubMed |
| 42,197,518 | Investigating the Antimycobacterial, Antibiofilm, and Antioxidant Activities of Plant Extracts Against Mycobacterium smegmatis. | Microorganisms | 2026 | https://conductscience.org/library/papers/42197518 | PubMed |
| 42,197,401 | Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin: Mechanisms of Action, Drug Interactions, Adverse Effects and Use in Special Situations. | Microorganisms | 2026 | https://conductscience.org/library/papers/42197401 | PubMed |
| 42,115,223 | Prevalence and associated factors of rifampicin resistance pulmonary tuberculosis among HIV-positive patients in Bahir Dar, Northwest, Ethiopia. | Sci Rep | 2026 | https://conductscience.org/library/papers/42115223 | PubMed |
| 42,074,413 | Predictors of Treatment Outcomes Among HIV-Positive Patients with Drug-Resistant Tuberculosis in Rural Eastern Cape, South Africa: A Retrospective Cohort Study. | Int J Environ Res Public Health | 2026 | https://conductscience.org/library/papers/42074413 | PubMed |
| 42,046,646 | Current and emerging therapies for pulmonary tuberculosis in adults. | BMJ Med | 2026 | https://conductscience.org/library/papers/42046646 | PubMed |
| 42,012,189 | The Mycobacterium tuberculosis Rv0132c Gene Product Mtb-FGD2 Can Act as an F420-Dependent Glucose Dehydrogenase. | Proteins | 2026 | https://conductscience.org/library/papers/42012189 | PubMed |
| 41,893,419 | Evaluating Treatment and Safety Outcomes of a Shorter Regimen for Drug-Resistant TB in Nigeria: An Implementation Research Study. | Trop Med Infect Dis | 2026 | https://conductscience.org/library/papers/41893419 | PubMed |
| 41,887,661 | Armed conflict intensity and inequalities in tuberculosis outcomes in Colombia municipalities, 2008-2019. | BMJ Glob Health | 2026 | https://conductscience.org/library/papers/41887661 | PubMed |
| 41,859,056 | Application Research of Targeted Next-Generation Sequencing Technology Based on Bronchoalveolar Lavage Fluid in the Diagnosis of Pulmonary Tuberculosis and Drug-Resistance Detection. | Infect Drug Resist | 2026 | https://conductscience.org/library/papers/41859056 | PubMed |
| 41,810,308 | Epidemiology of drug-resistant tuberculosis in Hunan China over a 10-year period. | Front Public Health | 2026 | https://conductscience.org/library/papers/41810308 | PubMed |
| 41,742,015 | Assessing the efficacy of combined treatment using bedaquiline against clinical isolates of multidrug-resistant Mycobacterium tuberculosis in vitro and the macrophage model. | BMC Microbiol | 2026 | https://conductscience.org/library/papers/41742015 | PubMed |
| 41,710,375 | Diagnosis and Therapeutic Challenges of Drug-Resistant Tuberculosis Infection After Kidney Transplantation: A Rare Case Report. | Infect Drug Resist | 2026 | https://conductscience.org/library/papers/41710375 | PubMed |
| 41,680,935 | Spatiotemporal epidemiology, geographic hotspots, and risk factor associations of drug-resistant tuberculosis incidence in Indonesia: a Bayesian hierarchical modelling approach. | Infect Dis Poverty | 2026 | https://conductscience.org/library/papers/41680935 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35342000
GET https://conductscience.org/api/papers/v1/35342000/cited_by?page=2